Poverty and genes shape health outcomes in substance users

Polygenic risk factors for comorbid diagnoses in individuals with substance use disorders: A phenome-wide survival analysis.

Psychological medicine • • Moderately Relevant
🤖

AI Summary

This groundbreaking study examined how genetic factors and social circumstances shape the risk of developing multiple health conditions in people with substance use disorders (SUDs). Using data from nearly 400,000 individuals in the All of Us research database, researchers tracked what happened after people received their first SUD diagnosis. They found that poverty was the strongest predictor of lifetime SUD risk, with people earning less than $10,000 annually being 4.18 times more likely to develop an SUD compared to those earning $100,000-$150,000. Beyond income, other social factors like housing instability and limited access to healthcare played significant roles in determining who develops SUDs.

The study also analyzed genetic risk scores for conditions commonly linked to substance use, including cannabis use disorders, alcohol use disorders, depression, trauma-related conditions, and schizophrenia. Researchers discovered 86 genetically-influenced health conditions that developed after the initial SUD diagnosis, spreading across multiple body systems. Notably, genetic predispositions for psychiatric conditions—especially for posttraumatic stress disorder and schizophrenia—strongly predicted the timing and severity of subsequent diagnoses in people with existing SUDs. This suggests that genetic factors don't just influence whether someone develops an SUD, but also what additional health problems they're likely to face afterward.

These findings have important implications for cannabis and substance use more broadly: they demonstrate that the relationship between genetics, environment, and substance use is deeply interconnected. Rather than viewing substance use disorders as simply individual choices or purely genetic destiny, this research highlights how poverty and social inequity fundamentally shape health trajectories. For people using cannabis or other substances, understanding these genetic and social risk factors could help healthcare providers identify those most vulnerable to developing co-occurring mental health and medical conditions, enabling earlier intervention and more personalized treatment approaches.

📄 Original Abstract

Persons with substance use disorders (SUD) often suffer from additional comorbidities. Researchers have explored this overlap via phenome-wide association studies (PheWASs). However, PheWASs are largely cross-sectional, limiting our understanding of whether diagnoses predate the development of an SUD. We characterize whether polygenic scores (PGSs) are associated with time to comorbid diagnoses in electronic health records (EHR) after the first documented SUD diagnosis. Using data from All of Us (N = 393,596), we explored: (1) whether social determinants of health (SDoHs) are associated with lifetime risk of SUD (N cases = 42,568) and (2) within a subset those with a diagnosed SUD and available genetic data SUD (N = 21,357), whether PGS for alcohol use disorders, cannabis use disorders, depression, externalizing, posttraumatic stress disorder, and schizophrenia were associated with subsequent diagnoses via a phenome-wide survival analysis. Multiple SDoHs were associated with lifetime SUD diagnosis, with annual household income having the largest overall associations (e.g. <$10 K annually vs $100 K-$150 K annually: OR = 4.18; 95% CI = 3.92, 4.45). There were 86 phenome-wide significant PGS associations with subsequent diagnoses across various bodily systems. PGSs for alcohol use disorders, posttraumatic stress disorder, and schizophrenia were each associated with time to their respective diagnoses. Social determinants, especially those related to income, have profound associations with lifetime SUD risk. Additionally, PGSs for psychiatric conditions are associated with multiple post-SUD diagnoses within those with a SUD, suggesting PGS may capture information beyond lifetime risk, including timing and severity of comorbidities related to SUD.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.